News Room

  • August 4, 2015
    Two Altasciences Executives Named PharmaVOICE 100 Most Inspiring People in the Life-Sciences Industry
    LAVAL, QC, Canada (Aug. 4, 2015) — Altasciences, a provider of top tier customer-tailored early phase clinical trial services, is pleased to announce that Chris Perkin, CEO at Altasciences, and his colleague, Dr. Brad Vince, CEO and Medical Director at Vince & Associates Clinical Research, an Altasciences company, have been named two of the 100 Most Inspiring People in the Life-Sciences Industry by PharmaVOICE magazine.
  • July 15, 2015
    Dr. Anahita Keyhani Joins Algorithme Pharma Laboratory Leadership as Director, Method Development

    (Laval, Québec, Canada, July 15, 2015) – Algorithme Pharma, a full service provider focused on early stage clinical research with over twenty years of experience, proudly announces the addition of Dr. Anahita Keyhani to the Algorithme Pharma family. Dr. Keyhani brings almost two decades of experience to her new role as Director, Method Development, previously Senior Research Scientist at Charles River Laboratories.

  • March 19, 2015
    Algorithme Pharma — Proud Member of the Clinical Data Interchanges Standards Consortium

    Algorithme Pharma, an Altasciences company, is now a proud member of the Clinical Data Interchanges Standards Consortium (CDISC), a non-profit organization harmonizing clinical data and streamlining research processes, from protocol through analysis and reporting, including the use of electronic health records to facilitate the collection of high quality research data.

  • March 3, 2015
    Vince & Associates Clinical Research Completes CymaBay Therapeutics’ Clinical Trial of Arhalofenate in Combination with Febuxostat

    Vince & Associates Clinical Research, a premier provider of early phase clinical research services, announced the completion of CymaBay Therapeutics’ Phase II clinical trial of arhalofenate administered in combination with febuxostat (Uloric™, Takeda Pharmaceutical Company Limited) by successfully enrolling thirty two study volunteers diagnosed with gout. Arhalofenate is being tested for the treatment of gout.

  • February 24, 2015
    Vince & Associates Clinical Research Wins Six CRO Leadership Awards

    Vince & Associates Clinical Research, a premier provider of early phase clinical research services, has been awarded six CRO Leadership Awards in the following categories: Quality, Productivity, Regulatory and Innovation in three sectors – Emerging Pharma, Biotech and Emerging Biotech.

Pages